Clipos™ Tanespimycin (17-AAG) Encapsulated Liposomes


Catalog:CDEPG-29

Unit Size:2 mL, 10 mL

INQUIRY Datasheet

Specifications
Description PEGylated liposomes containing Hsp90 inhibitor Tanespimycin (17-AAG). Tanespimycin exhibits 100-fold higher binding affinity to HSP90 derived from tumor cells vs normal cells, and induces apoptosis, necrosis, autophagy, and mitophagy. Tanespimycin is insoluble in aqueous media. This product is a pre-formulated liposomal version of Tanespimycin which is supplied ready to use in vitro or in vivo. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.
Lipid composition PEGylated Liposomes
Liposome Size 70-120 nm
Lipid Molar Concentration 60 mM
Encapsulated Drug Tanespimycin
Drug concentration 2.5 mg/mL
Inside Buffer 300 mM sucrose
Outside Buffer 300 mM sucrose
Storage 2 °C to 8 °C (do not freeze), protect from light
Shelf-life At least 1 month
Related Products
Product Name Catalog Lipid composition Liposome Size Price
Clipos™ Cefixime Encapsulated Liposomes CDEPG-03 PEGylated liposomes 70-120 nm INQUIRY
Clipos™ Gilteritinib (ASP2215) Encapsulated Liposomes CDEPG-19 HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3 molar ratio) 70-120 nm INQUIRY
Clipos™ Lxabepilone (BMS-247550) Encapsulated Liposomes CDEPG-20 PEGylated Liposomes 70-120 nm INQUIRY
Clipos™ Rocaglamide Encapsulated Liposomes CDEPG-21 PEGylated Liposomes 70-120 nm INQUIRY
Clipos™ SP600125 Encapsulated Liposomes CDEPG-22 PEGylated Liposomes 70-120 nm INQUIRY
Clipos™ Rapamycin (Sirolimus) Encapsulated Liposomes CDEPG-23 PEGylated Liposomes 70-120 nm INQUIRY
Clipos™ Lificiguat (YC-1) Encapsulated Liposomes CDEPG-24 PEGylated Liposomes 70-120 nm INQUIRY
Clipos™ Eganelisib (IPI-549) Encapsulated Liposomes CDEPG-25 PEGylated Liposomes 70-120 nm INQUIRY
Products
Fill out the form below
to receive a quote

GET A QUOTE

  • (USA)
  • (Europe)
Cookie Policy | Privacy Policy | Copyright © 2024 CD Bioparticles. All rights reserved.
0
Inquiry Basket
Inquiry